#

Freedom Holding

: 367
Equillium develops treatments for severe autoimmune diseases / Photo: Shutterstock
Small Caps·
Biotech firm Equillium loses third of market value in a day after Ono no-go
MAIA’s lead candidate targets tumor cells in non-small-cell lung cancer / Photo: Shutterstock
Small Caps·
Oncology company MAIA advances on news of private placement
ImmunityBio is focused on novel cancer therapies / Photo: Unsplash/National Cancer Institute
Small Caps·
EF Hutton sees over 600% upside in biotech small cap ImmunityBio
Achieve is developing the world’s first drug for vaping addiction. Photo: Shutterstock
Small Caps·
Third time’s the charm: How Achieve Life Sciences developed a breakthrough drug for vaping addiction
Oprah Winfrey (right) hosted a special on weight-loss drugs this year / Photo: YouTube / ABC News
Small Caps·
The skinny on investing in the weight-loss drug market
Enovix, a company developing next-generation batteries, is unprofitable / Photo: Enovix
Small Caps·
Freedom Finance analyst highlights two small caps for risk-tolerant investors
The CEO of Freedom Holding Corp. at the Nasdaq MarketSite in New York / Photo: Instagram / Timur Turlov
News·
Freedom Holding skyrockets 600% in five years on Nasdaq
The 12-month target price for one of the stocks, e.l.f. Beauty, suggests 86% upside / Photo: Facebook Elfcosmetics
Small Caps·
Freedom Finance analyst spotlights two small caps with big potential
Lumen Technologies returned investors over 500% in the period, but the stock’s growth potential is likely exhausted / Photo: lumen.com
Small Caps·
Freedom spotlights five small-cap stocks with third-quarter returns over 100%
Achieve will use the proceeds to advance its vaping drug / Photo: Shutterstock
Small Caps·
Vaping addiction drug developer Achieve to sell up to $50 million of stock
One of the companies, Innovative Solutions, is an international supplier to the commercial transport, military, and business aviation markets / Photo: Business Wire
Small Caps·
Freedom Broker spotlights small-cap stocks to look at
Achieve Life Sciences is developing the first therapy to treat vaping addiction / Photo: linkedin.com/company/achieve-life-sciences
Small Caps·
Vaping addiction treatment developer changes CEO, possibly ahead of sale
Load more